Direct Action of Serotonin on Prolactin, Growth Hormone, Corticotropin and Luteinizing Hormone Release in Cocultures of Anterior and Posterior Pituitary Lobes: Autocrine and/or Paracrine Action of Vasoactive Intestinal Peptide

There is extensive evidence that serotonin (5-HT) is implicated in the neuroendocrine control regulating the secretion of several anterior pituitary hormones. It has also been reported that the posterior pituitary is necessary for prolactin (PRL) response to 5-HT as well as to suckling, in which 5-HT implication has been demonstrated. As we have previously shown that vasoactive intestinal peptide (VIP) mediates through an autocrine or paracrine action the PRL release induced by insulin-like growth factor I, thyrotropin-releasing hormone (TRH) and dopamine withdrawal, the aim of the present work was to determine whether 5-HT has a direct action on pituitary secretion and to study the possible role of pituitary VIP in this situation. Cells from the anterior pituitary lobe (AP) were cultured either alone or together with cells from the posterior pituitary lobe (PP). As melanotropes from PP express glucocorticoid receptors in vitro, both AP cultures and cocultures of AP/PP cells were incubated in the presence or absence of corticosterone (0.1 µg/ml), thus designing four experimental conditions. Then both AP and mixed cultures were incubated with 5-HT (100 nM) for 20, 45 and 180. The release of PRL, growth hormone (GH), corticotropin (ACTH) and luteinizing hormone (LH) was stimulated by 5-HT, but only in cocultures of AP/PP cells preincubated with corticosterone, whereas follicle-stimulating hormone and thyroid-stimulating hormone release was not modified. As AP cultures did not show any response to 5-HT, both in the presence or absence of corticosterone, and as melanotropes are the main cellular type present in the PP cultures, we studied the response of α-melanocyte-stimulating hormone (αMSH) to 5-HT in PP cells cultured with or without corticosterone. Serotonin did not modify αMSH release either in the absence or the presence of corticosterone. VIP release was also stimulated by 5-HT in the cocultures, and the time response profile was only similar to that of PRL. In order to study whether pituitary VIP is implicated in 5-HT action, cocultures preincubated with corticosterone were incubated in the presence of 5-HT, a VIP-receptor antagonist (VIP-At) or simultaneously with 5-HT plus VIP-At. PRL response to 5-HT was abolished by the simultaneous presence of VIP-At, whereas GH, ACTH and LH response remained unchanged. These data demostrate that: (1) 5-HT stimulates the secretion of PRL, GH, ACTH, LH and VIP acting directly at pituitary level on PP, probably by releasing an unidentified mediator from melanotropes; (2) glucocorticoids make the response of AP cells to 5-HT possible due to the presence of PP cells in the coculture; (3) PRL response to 5-HT is mediated through an autocrine and/or paracrine action of VIP.

[1]  M. Low,et al.  Two Distinct Pituitary Cell Lines from Mouse Intermediate Lobe Tumors: A Cell that Produces Prolactin-Regulating Factor and a Melanotroph. , 1997, Endocrinology.

[2]  J. Balsa,et al.  Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion. , 1996, Endocrinology.

[3]  F. Mounier,et al.  Differential sites of action of 8OHDPAT, a 5HT1A agonist, on ACTH and PRL secretion in the rat. , 1995, Neuroendocrinology.

[4]  J. Balsa,et al.  Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system. , 1994, Endocrinology.

[5]  J. V. Van Beeumen,et al.  In vitro evidence that an 11-kilodalton N-terminal fragment of proopiomelanocortin is a growth factor specifically stimulating the development of lactotrophs in rat pituitary during postnatal life. , 1994, Endocrinology.

[6]  T. Görcs,et al.  Does alpha-melanocyte-stimulating hormone from the pars intermedia regulate suckling-induced prolactin release? Supportive evidence from morphological and functional studies. , 1993, Endocrinology.

[7]  S. Chiocchio,et al.  Serotonin, a neurotransmitter involved in the regulation of luteinizing hormone release. , 1993, Endocrine reviews.

[8]  U. Knigge,et al.  Effect of serotonin 5-HT1, 5-HT2, and 5-HT3 receptor antagonists on the prolactin response to restraint and ether stress. , 1992, Neuroendocrinology.

[9]  K. Krobert,et al.  In vivo effects of serotonergic agents on alpha-melanocyte-stimulating hormone secretion. , 1991, Neuroendocrinology.

[10]  C. Oliver,et al.  Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. , 1990, Endocrinology.

[11]  M. Laudon,et al.  Prolactin-releasing factor: cellular origin in the intermediate lobe of the pituitary. , 1990, Endocrinology.

[12]  S. Reichlin,et al.  Synthesis and secretion of vasoactive intestinal peptide by rat fetal cerebral cortical and hypothalamic cells in culture. , 1989, Endocrinology.

[13]  C. Bethea,et al.  Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion , 1989, Neuropharmacology.

[14]  B. Chronwall,et al.  Rat intermediate lobe in culture: A histological and biochemical characterization , 1988, Peptides.

[15]  J. Funder,et al.  Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. , 1988, Endocrine reviews.

[16]  N. Ben-Jonathan,et al.  Posterior pituitary lobectomy abolishes the suckling-induced rise in prolactin (PRL): evidence for a PRL-releasing factor in the posterior pituitary. , 1987, Endocrinology.

[17]  S. Mercille,et al.  Tissue-specific dopaminergic regulation of the glucocorticoid receptor in the rat pituitary. , 1987, Endocrinology.

[18]  H. Imura,et al.  Involvement of growth hormone (GH)-releasing factor in GH secretion induced by serotoninergic mechanisms in conscious rats. , 1986, Endocrinology.

[19]  A. Negro-Vilar,et al.  Prolactin release after 5-hydroxytryptophan treatment requires an intact neurointermediate pituitary lobe. , 1986, Endocrinology.

[20]  H. Kaji,et al.  Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats. , 1985, Endocrinology.

[21]  S. Melmed,et al.  Insulin suppresses triiodothyronine-induced growth hormone secretion by GH3 rat pituitary cells. , 1985, Endocrinology.

[22]  M. Palkovits,et al.  Induced expression of the glucocorticoid receptor in the rat intermediate pituitary lobe. , 1985, Science.

[23]  M. Molitch,et al.  Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. , 1985, Endocrinology.

[24]  H. Imura,et al.  Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin secretion induced by serotonin in the rat. , 1985, European journal of pharmacology.

[25]  B. McEwen,et al.  Adrenal steroid modulation of vasoactive intestinal peptide effect on serotonin1 binding sites in the rat brain shown by in vitro quantitative autoradiography. , 1985, Neuroendocrinology.

[26]  M. Palkovits,et al.  On the origin of the serotonergic input to the intermediate lobe of the rat pituitary , 1984, Brain Research.

[27]  J. Taylor,et al.  Dorsal raphe-hypothalamic projections provide the stimulatory serotonergic input to suckling-induced prolactin release. , 1983, Endocrinology.

[28]  J. Randle,et al.  Differential control of the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary. Response to serotonin. , 1983, Neuroendocrinology.

[29]  D. Krieger,et al.  Serotonin immunoreactive nerve fibers and terminals in the rat pituitary—light-and electron-microscopic studies , 1983, Neuroscience.

[30]  M. Palkovits,et al.  Serotonergic innervation of the rat pituitary intermediate lobe: decrease after stalk section. , 1983, Endocrinology.

[31]  A. Negro-Vilar,et al.  Serotonin and adrenocorticotropin (ACTH) release: direct effects at the anterior pituitary level and potentiation of arginine vasopressin-induced ACTH release. , 1983, Endocrinology.

[32]  K. Westlund,et al.  Localization of serotonin fibers in the rat adenohypophysis. , 1982, Endocrinology.

[33]  H. Imura,et al.  Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood. , 1982, Endocrinology.

[34]  S. Yen,et al.  Serotonergic mechanism in the control of beta-endorphin and ACTH release in male rats. , 1982, Life sciences.

[35]  J. D. Neill,et al.  Involvement of the neurointermediate lobe of the pituitary gland in the secretion of prolactin and luteinizing hormone in the rat. , 1982, Life sciences.

[36]  J. C. Porter,et al.  Dopamine in hypophysial portal plasma and prolactin in systemic plasma of rats treated with 5-hydroxytryptamine. , 1981, Endocrinology.

[37]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[38]  P. Vallet,et al.  Rat posterior lobe modulates growth hormone release in vivo and in vitro. , 1980, Life sciences.

[39]  S. Lorens,et al.  Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei , 1979, Brain Research.

[40]  J. Simpkins,et al.  Serotonergic control of prolactin release in male rats. , 1979, Life sciences.

[41]  L. Krulich,et al.  Stimulation of Growth Hormone Release by Intraventricular Administration of 5HT or Quipazine in Unanesthetized Male Rats 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[42]  S. Lamberts,et al.  The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide. , 1978, Endocrinology.

[43]  J. Balsa,et al.  Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release. , 1996, Endocrinology.

[44]  J. Goudreau,et al.  5-Hydroxytryptamine2 receptor-mediated regulation of periventricular-hypophysial dopaminergic neuronal activity and the secretion of alpha-melanocyte-stimulating hormone. , 1994, Journal of Pharmacology and Experimental Therapeutics.

[45]  L. Frawley,et al.  Alpha-melanocyte-stimulating hormone is a mammotrophic factor released by neurointermediate lobe cells after estrogen treatment. , 1992, Endocrinology.

[46]  M. Baes,et al.  Paracrine interactions in the anterior pituitary: role in the regulation of prolactin and growth hormone secretion , 1986 .

[47]  B. Koch,et al.  In vitro regulation of ACTH release from neurointermediate lobe of rat hypophysis. II. Effect of neurotransmitters. , 1979, Neuroendocrinology.

[48]  W. Daughaday,et al.  Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. , 1970, Endocrinology.